Dr. Albala on Patient Selection for Robotic Surgery in Prostate Cancer

David Albala, MD
Published: Wednesday, Feb 08, 2017



David Albala, MD, urologist and medical director, Associated Medical Professionals, discusses patients with prostate cancer who are best suited to be treated with robotic surgery.

According to Albala, all patients who are surgical candidates for the procedure that they're going to undergo, can be done robotically. If a patient is a candidate for a prostatectomy—whether the procedure is done with a retropubic, perineal, or a robotic approach—then they can be operated on robotically.

Obese patients can be be treated with robotic surgery with the new da Vinci system, which includes longer reaches for the instruments, explains Albala. Despite challenges with some of the earlier porotypes of the robot, these procedures are now able to be done with great ease and yield beneficial results for patients. Overall, anything that can be accomplished with an open procedure, he says, can also be done robotically.


David Albala, MD, urologist and medical director, Associated Medical Professionals, discusses patients with prostate cancer who are best suited to be treated with robotic surgery.

According to Albala, all patients who are surgical candidates for the procedure that they're going to undergo, can be done robotically. If a patient is a candidate for a prostatectomy—whether the procedure is done with a retropubic, perineal, or a robotic approach—then they can be operated on robotically.

Obese patients can be be treated with robotic surgery with the new da Vinci system, which includes longer reaches for the instruments, explains Albala. Despite challenges with some of the earlier porotypes of the robot, these procedures are now able to be done with great ease and yield beneficial results for patients. Overall, anything that can be accomplished with an open procedure, he says, can also be done robotically.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x